A New Approach to Prevent Respiratory Diseases
Scientists may be moving closer to one of medicine’s biggest goals: a single vaccine that protects against many diseases. Researchers at Stanford Medicine have developed an experimental “universal” vaccine that works as a simple nasal spray. In early experiments, the spray protected mice from several respiratory threats, including viruses, bacteria, and even allergens.
Traditional vaccines usually train the immune system to recognize one specific pathogen. Because viruses and bacteria constantly evolve, scientists often have to update vaccines, as seen with seasonal flu shots. The new nasal spray takes a different approach. Instead of targeting a single germ, it strengthens the lungs’ overall immune defenses so they can respond quickly to many different threats.
How the Nasal Vaccine Works
The experimental vaccine stimulates both the innate immune system, which reacts immediately to invaders, and the adaptive immune system, which creates long-term protection. By activating both systems, the spray keeps the lungs in a state of readiness for months and helps them respond rapidly when pathogens appear.
During laboratory experiments, researchers gave mice the nasal spray and later exposed them to dangerous microbes. The vaccinated mice resisted infections caused by SARS-CoV-2, other coronaviruses, and harmful bacteria such as Staphylococcus aureus and Acinetobacter baumannii. Their lungs contained far fewer pathogens, and their immune systems responded much faster than those of unvaccinated animals.
Protection Even Against Allergies
The researchers also discovered another surprising benefit. The vaccine reduced allergic reactions in the respiratory system. When the team exposed vaccinated mice to house dust mites, the animals developed far fewer asthma-like symptoms and much less lung inflammation. This finding suggests that the spray may help prevent certain allergic responses as well.
What Comes Next
Although the results look promising, scientists have only tested the vaccine in mice so far. Researchers must now conduct human trials to confirm whether the nasal spray is safe and effective for people. If future studies succeed, this universal vaccine could simplify disease prevention by protecting people from multiple respiratory threats with a single treatment.
